MUVON Therapeutics is spin-off from the University of Zurich developing an autologous cell therapy for the treatment of diseases related to skeletal muscle damage or degradation. The technology enables the targeted isolation of muscle precursor.
MUVON Therapeutics is spin-off from the University of Zurich developing an autologous cell therapy for the treatment of diseases related to skeletal muscle damage or degradation. The technology enables the targeted isolation of muscle precursor.
MUVON Therapeutics is spin-off from the University of Zurich developing an autologous cell therapy for the treatment of diseases related to skeletal muscle damage or degradation. The technology enables the targeted isolation of muscle precursor.